Du Zhi, Li Jiabin, Li Wei, Fu Hao, Ding Jieying, Ren Guofei, Zhou Linying, Pi Xionge, Ye Xiaoli
Department of Pharmacy, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang, China.
Research Center for Clinical Pharmacy, Zhejiang University, Hangzhou, Zhejiang, China.
Front Microbiol. 2023 Sep 1;14:1233840. doi: 10.3389/fmicb.2023.1233840. eCollection 2023.
Diarrhea is among the top five causes of morbidity and mortality in children. Dysbiosis of the gut microbiota is considered the most important risk factor for diarrhea. Prebiotics have shown efficacy in treating diarrhea by regulating the balance of the gut microbiota .
In this study, we used an fermentation system to prevent the interference of host-gut microbe interactions during examination and investigated the effect of fructo-oligosaccharides (FOS) on gut microbiota composition and metabolism in 39 pediatric patients with functional diarrhea.
16S rRNA sequencing revealed that FOS significantly improved α- and β-diversity in volunteers with pediatric diarrhea ( < 0.05). This improvement manifested as a significant increase (LDA > 2, < 0.05) in probiotic bacteria (e.g., ) and a significant inhibition (LDA > 2, < 0.05) of harmful bacteria (e.g., ). Notably, the analysis of bacterial metabolites after FOS treatment showed that the decrease in isobutyric acid, isovaleric acid, NH, and HS levels was positively correlated with the relative abundance of . This decrease also showed the greatest negative correlation with the abundance of . Random forest analysis and ROC curve validation demonstrated that gut microbiota composition and metabolites were distinct between the FOS treatment and control groups (area under the curve [AUC] > 0.8). Functional prediction using PICRUSt 2 revealed that the FOS-induced alteration of gut microbiota was most likely mediated by effects on starch and sucrose metabolism.
This study is the first to evince that FOS can modulate gut microbial disorders in children with functional diarrhea. Our findings provide a framework for the application of FOS to alleviate functional diarrhea in children and reduce the use of antibiotics for managing functional diarrhea-induced disturbances in the gut microbiota.
腹泻是儿童发病和死亡的五大主要原因之一。肠道微生物群失调被认为是腹泻最重要的危险因素。益生元已显示出通过调节肠道微生物群平衡来治疗腹泻的功效。
在本研究中,我们使用了一种发酵系统,以防止在检测过程中宿主-肠道微生物相互作用的干扰,并研究了低聚果糖(FOS)对39例小儿功能性腹泻患者肠道微生物群组成和代谢的影响。
16S rRNA测序显示,FOS显著改善了小儿腹泻志愿者的α和β多样性(P<0.05)。这种改善表现为益生菌(如)显著增加(线性判别分析>2,P<0.05),有害菌(如)受到显著抑制(线性判别分析>2,P<0.05)。值得注意的是,FOS治疗后细菌代谢产物分析表明,异丁酸、异戊酸、NH和HS水平的降低与的相对丰度呈正相关。这种降低与的丰度也呈现出最大的负相关。随机森林分析和ROC曲线验证表明,FOS治疗组和对照组之间的肠道微生物群组成和代谢产物明显不同(曲线下面积[AUC]>0.8)。使用PICRUSt 2进行的功能预测表明,FOS诱导的肠道微生物群改变最有可能是通过对淀粉和蔗糖代谢的影响来介导的。
本研究首次表明FOS可以调节小儿功能性腹泻患者的肠道微生物紊乱。我们的研究结果为应用FOS缓解小儿功能性腹泻以及减少使用抗生素治疗功能性腹泻引起的肠道微生物群紊乱提供了一个框架。